| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9403 |
| Human Intestinal Absorption | HIA+ | 0.9468 |
| Caco-2 Permeability | Caco2+ | 0.6915 |
| P-glycoprotein Substrate | Substrate | 0.5094 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7448 |
| Non-inhibitor | 0.8339 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8393 |
| Distribution |
| Subcellular localization | Mitochondria | 0.9017 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8198 |
| CYP450 2D6 Substrate | Non-substrate | 0.8708 |
| CYP450 3A4 Substrate | Substrate | 0.5099 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.6952 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7031 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8884 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7072 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8059 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7761 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9358 |
| Non-inhibitor | 0.8238 |
| AMES Toxicity | Non AMES toxic | 0.8961 |
| Carcinogens | Non-carcinogens | 0.7209 |
| Fish Toxicity | High FHMT | 0.9896 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9989 |
| Honey Bee Toxicity | High HBT | 0.5659 |
| Biodegradation | Ready biodegradable | 0.5773 |
| Acute Oral Toxicity | IV | 0.6017 |
| Carcinogenicity (Three-class) | Warning | 0.5262 |